Thigpen Jt

A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas

R. Zaino, J. Thigpen, T. Sedlacek, 1983, Cancer.

Cisplatin as Second‐Line Chemotherapy in the Treatment of Advanced or Recurrent Leiomyosarcoma of the Uterus A Phase II Trial of the Gynecologic Oncology Group

G. Wilbanks, J. Thigpen, J. Blessing, 1986, American journal of clinical oncology.

Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a Gynecologic Oncology Group study.

E. Yordan, J. Thigpen, H. Homesley, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized comparison of doxorubicin alone versus doxorubicin plus cyclophosphamide in the management of advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study.

P. Disaia, E. Yordan, C. Evers, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of adriamycin in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study.

J. Thigpen, C. Mangan, J. Blessing, 1979, Cancer treatment reports.

Phase II trial of cisplatin in the treatment of patients with advanced or recurrent mixed mesodermal sarcomas of the uterus: a Gynecologic Oncology Group Study.

P. Disaia, J. Thigpen, J. Orr, 1986, Cancer treatment reports.

High-dose chemotherapy in ovarian carcinoma.

J. Thigpen, V. Herrin, Thigpen Jt, 1999, Seminars in oncology.

Phase II trial of dianhydrogalactitol in advanced soft tissue and bony sarcomas: a Southwest Oncology Group study.

Samson Mk, Thigpen Jt, 1979 .